| # | Drug | Count |
|---|---|---|
| 0 | LEVONORGESTREL | 360 |
| 1 | METHOTREXATE SODIUM | 325 |
| 2 | COPPER | 311 |
| 3 | METHOTREXATE | 299 |
| 4 | ADALIMUMAB | 274 |
| 5 | ESTRADIOL | 241 |
| 6 | PREDNISONE | 229 |
| 7 | ACETAMINOPHEN | 220 |
| 8 | ETANERCEPT | 189 |
| 9 | LEVOTHYROXINE SODIUM | 186 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PAROMOMYCIN SULFATE | 4 | 0.0377 |
| 1 | PRAMLINTIDE ACETATE | 3 | 0.0294 |
| 2 | APRACLONIDINE | 2 | 0.0180 |
| 3 | TERCONAZOLE | 9 | 0.0108 |
| 4 | CEFIXIME | 29 | 0.0095 |
| 5 | COPPER | 311 | 0.0072 |
| 6 | PENCICLOVIR | 2 | 0.0055 |
| 7 | ERTUGLIFLOZIN | 6 | 0.0054 |
| 8 | ADALIMUMAB-AFZB | 14 | 0.0052 |
| 9 | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | 4 | 0.0051 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 547 |
| 1 | Progestin [EPC] | 527 |
| 2 | Corticosteroid [EPC] | 509 |
| 3 | Estrogen [EPC] | 502 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 364 |
| 5 | Progestin-containing Intrauterine System [EPC] | 361 |
| 6 | Copper-containing Intrauterine Device [EPC] | 314 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 295 |
| 8 | Benzodiazepine [EPC] | 256 |
| 9 | Vitamin C [EPC] | 239 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Copper-containing Intrauterine Device [EPC] | 314 | 0.0063 |
| 1 | Estrogen [EPC] | 502 | 0.0027 |
| 2 | Calcitonin [EPC] | 8 | 0.0026 |
| 3 | Leptin Analog [EPC] | 3 | 0.0024 |
| 4 | Interleukin-17 Receptor A Antagonist [EPC] | 4 | 0.0019 |
| 5 | Estrogen Agonist/Antagonist [EPC] | 5 | 0.0019 |
| 6 | Progestin [EPC] | 527 | 0.0018 |
| 7 | Provitamin D2 Compound [EPC] | 47 | 0.0016 |
| 8 | Serotonin-4 Receptor Agonist [EPC] | 1 | 0.0015 |
| 9 | Nitroimidazole Antimicrobial [EPC] | 98 | 0.0015 |